Pierre FABRE donates the majority equity interest in his company to his Foundation and appoints Jean-Pierre GARNIER general manager of Pierre FABRE SA

Castres, 29 August 2008 — Faithful to the commitment made in 2005 to his employees, Mr. Pierre FABRE asked the Pierre Fabre Foundation’s board of directors to accept the donation of 100% of the equity of Pierre Fabre Participation, a holding company with a 60% share in Laboratoires Pierre Fabre. The aim of this operation is to secure the long-term independence of Pierre Fabre SA, a company founded in 1961 in Castres with a turnover of €1.7 billion in pharmaceuticals, family medical products and dermocosmetics.

At the same time, Mr. Pierre FABRE expressed his intention to transform Pierre Fabre SA into a company under a Supervisory Committee, chaired by him, with Mr. GARNIER heading the management board.

Mr. Jean-Pierre GARNIER, 60, was CEO of the world’s second biggest pharmaceuticals group, GlaxoSmithKline Beecham, until last May. An Officer of the Legion of Honour, Mr. GARNIER has been a member of the French Healthcare Industries Strategic Council since the organisation was founded.

When announcing this decision, Mr. Pierre FABRE stated: "we are fortunate to have a man with so much experience in the global pharmaceutics arena in the person of Jean-Pierre GARNIER, who will enable us to successfully sustain the considerable R&D efforts the company has been making over the past few years and amplify its growth."


About Pierre Fabre SA

Pierre Fabre SA achieved a turnover of €1.7 billion in 2007 and employs a workforce of nearly 10,000. It ranks as the second biggest independent laboratory in France and leads the in-pharmacy cosmetics sector, which accounts for half the group’s turnover.

The Pierre Fabre Foundation is a registered charity founded by order of the prime minister on 8 April 1999. It is chaired by Mr. Pierre Fabre and works to promote good pharmaceutical practice and improve healthcare in developing countries.


Source: Company

[Read more!]

IEB (Institut Européen de Biologie Cellulaire) — Company Profile

Institut Européen de Biologie Cellulaire 18, avenue de l'Europe 31520 Ramonville St Agne (Toulouse) France Tel.: +33 (0)5 62 88 73 00 Fax: +33 (0)5 62 88 73 01 Website: http://www.ieb.fr/

Created in 1993, the Institut Européen de Biologie cellulaire brought together scientists from the pharmaceutical industry. The research teams have developed and produced innovative biomimetic oligopeptides used by the largest cosmetic companies.

The assessed performances of our ingredients have given the I.E.B. the opportunity to register six international patents and to be awarded two trophies.

Our research team has developed and perfected an innovative concept of actives in dermo-cosmetology.

Our peptidic actives stimulate and strengthen the different skin functions. They also make up for physiopathological disorders linked to skin ageing and stress thanks to their regenerative capacities.

Spread through the skin, our biocompatible products have a perfectly determined action on the various elements making up the skin, without any systemic effect.



Source: Institut Européen de Biologie Cellulaire

Editor's Note: The IEB is part of the Unipex Group since May 2008.

[Read more!]

GTP Technology — Company Profile

GTP Technology Bâtiment Biostep Rue Pierre et Marie Curie — BP 48184 31681 Labège Cedex France Tel.: +33 (0)5 61 28 70 20 Fax: + 33 (0)5 61 28 70 21 Email: contact@gtptech.com Website: http://www.gtptech.com/

GTP Technology is a contract research organization providing tailor-made solutions for recombinant proteins expression and engineering.

Our services target pharmaceutical and cosmetic industry, biotech companies, food industry and academic laboratories, for numerous applications: high throughput screening, preclinical studies, functional and structural analysis...

GTP Technology is a biotech company dedicated to provide tailor-made solutions for the engineering and expression of recombinant proteins. The company was set up in 2000 by Eric Devic (Pharm.D. PhD) as a spin out from the Protein Engineering Department of P. Sabatier University in Toulouse, France.

GTP Technology offers its customers a comprehensive set of services for recombinant proteins, from gene cloning to protein production and purification and also, now, structural analysis with the Eiffel Biostructure platform. In addition, the company has extended its range of services and offers Real-Time PCR protocols development or optimization.

GTP Technology is renowned for its expertise — more than 200 proteins produced up to now — and for the quality of its services. As a result, the company has become one of the privileged partners of the main French pharmaceutical, biotech and food companies.

GTP Technology is located in Labege (near Toulouse), France.


Source: GTP Technology

[Read more!]